Impact Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Buy
3,476
+16
+0.5% +$1.4K 0.09% 201
2026
Q1
$295K Buy
3,460
+6
+0.2% +$535 0.09% 224
2025
Q4
$273K Buy
3,454
+16
+0.5% +$1.25K 0.08% 234
2025
Q3
$275K Buy
3,438
+24
+0.7% +$2.05K 0.08% 224
2025
Q2
$310K Buy
3,414
+4
+0.1% +$365 0.1% 198
2025
Q1
$320K Buy
3,410
+33
+1% +$2.96K 0.12% 190
2024
Q4
$307K Buy
+3,377
New +$322K 0.11% 196

Other funds holding CL

Impact Capital Partners's CL Position: Q2 2026 in Review

Impact Capital Partners increased its Colgate-Palmolive (CL) stake by 0.46% in Q2 2026, buying an estimated $1.4K and bringing the position to 3,476 shares worth $319K. The position accounts for 0.09% of the portfolio, ranked #201.

Impact Capital Partners first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $320K in Q1 2025. 467 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Impact Capital Partners held 3,476 shares of Colgate-Palmolive worth $319K as of Q2 2026.
  • Impact Capital Partners bought 16 Colgate-Palmolive shares in Q2 2026, an estimated $1.4K.
  • Colgate-Palmolive made up 0.09% of Impact Capital Partners's portfolio in Q2 2026, its #201 holding.
  • Impact Capital Partners first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • Impact Capital Partners's Colgate-Palmolive position peaked at $320K in Q1 2025.
  • 467 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Impact Capital Partners's 13F filing for Q2 2026, filed 14 Jul 2026.